术前慢性激素使用对未破裂腹主动脉瘤开放修复术后结局的影响
该回顾性队列研究基于2011至2023年美国外科医师学会国家手术质量改进计划数据,纳入5166例择期开放修复未破裂腹主动脉瘤患者,其中143例(2.8%)长期使用激素。调整混杂因素后,慢性激素使用与手术部位感染、肺炎、肺栓塞、输血、系统性感染、脓毒症、缺血性结肠炎及原瘤床出血风险升高独立相关,并与住院和ICU时间延长相关。
要点
- 慢性激素使用与开放修复未破裂腹主动脉瘤后多种术后并发症风险升高独立相关。
- 激素使用组手术部位感染、深部切口感染、肺炎、肺栓塞及原瘤床出血风险显著增加。
- 激素使用与住院时间和ICU停留时间延长相关,围术期管理需考虑此风险。
核心结论
- 慢性激素使用与开放修复未破裂腹主动脉瘤术后并发症风险升高相关,应在患者选择和围术期管理中予以考虑。
研究设计与样本
- 回顾性队列研究,使用2011至2023年美国外科医师学会国家手术质量改进计划数据,纳入5166例择期开放修复未破裂腹主动脉瘤患者,其中143例(2.8%)长期使用激素。
主要发现
- 调整术前和术中因素后,慢性激素使用与任何手术部位感染(aOR 2.02)、深部切口感染(aOR 4.91)、肺炎(aOR 1.70)、肺栓塞(aOR 5.18)、输血需求(aOR 1.61)、系统性感染(aOR 2.24)、脓毒症(aOR 3.02)、缺血性结肠炎(aOR 2.12)及原腹主动脉瘤部位出血(aOR 5.00)风险升高独立相关(均P < 0.05)。
- 激素使用与住院时间延长(β = 1.31天)和重症监护室停留时间延长(β = 0.94天)相关(P < 0.05)。
临床怎么用
- 在择期开放修复未破裂腹主动脉瘤前,应评估慢性激素使用情况,并将其纳入围术期风险分层和并发症预防策略。
局限性
- 证据等级为III级,为回顾性队列研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic corticosteroid use is associated with impaired wound healing and increased postoperative complications, but its impact on open surgical repair (OSR) of unruptured abdominal aortic aneurysms (AAAs) remains unclear. Given the physiologic stress of OSR, identifying risk factors is essential. We aimed to evaluate the association between chronic steroid use and 30-day postoperative outcomes following elective OSR of unruptured AAA. METHODS: This retrospective cohort study used data from the American College of Surgeons National Surgical Quality Improvement Program from 2011 to 2023. Patients undergoing OSR of unruptured AAA were identified and stratified by chronic steroid use. Thirty-day postoperative outcomes were compared between groups. Univariate and multivariate logistic regression models evaluated the association between chronic steroid use and postoperative complications. RESULTS: A total of 5,166 patients were included, with 143 (2.8%) on chronic steroids. After adjusting for preoperative and intraoperative factors, chronic steroid use was independently associated with increased risk of any surgical site infection (SSI) (adjusted odds ratio [aOR] 2.02), deep incisional SSI (aOR 4.91), pneumonia (aOR 1.70), pulmonary embolism (aOR 5.18), transfusion requirement (aOR 1.61), systemic infection (aOR 2.24), sepsis (aOR 3.02), ischemic colitis (aOR 2.12), and bleeding from the prior AAA site (aOR 5.00) (all P < 0.05). Steroid use was linked to longer hospital stay (β = 1.31 days) and intensive care unit length of stay (β = 0.94 days) (P < 0.05). CONCLUSION: Chronic steroid use is associated with increased risk of postoperative complications following OSR of unruptured AAA. These findings suggest that chronic steroid use should be considered during patient selection and perioperative management to optimize outcomes. LEVEL OF EVIDENCE: III.
引用
- Bitar ER, Bou Jaoude CR, Hassanieh J, et al. Impact of Preoperative Chronic Steroid Use on Postoperative Outcomes following Open Surgical Repair of Unruptured Abdominal Aortic Aneurysm. Ann Vasc Surg. 2025. PMID: 41043585. doi:10.1016/j.avsg.2025.09.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。